The covid-19 vaccine that was under development in Uganda has been finally given a green light for use to prevent the Covid virus by Uganda's National Drug Authority. The vaccine which is dubbed COVIDEX was developed locally by Uganda-based researcher Prof Patrick Ogwang.
According to sources, the vaccine which was given a go-ahead warning on Wednesday has already started to sell like hot cake and its price is already hiking. It is reported that on Tuesday when the vaccine was still awaiting its approval, it was already selling at UGX 10000 (approximately Ksh 303) but later on by Wednesday, the price had already hiked to around UGX 50000 (approximately Ksh 1520) per 200ml bottle.
The developer of the vaccine Prof Ogwang has assured the public that the vaccine is very effective in managing the virus and that it is a game-changer in preventing the spread of the virus. However, the developer has warned citizens against self-medication against the virus urging them to always consult before using it.
This is a big boost to not only East African countries but also the continent of Africa and the whole world especially during this period when there is a scarcity of Covid-19 vaccine supply.
Content created and supplied by: The..Saturday..Face (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More